Overview

Research Antibodies and Reagents Market is estimated to value over USD 14 billion by 2027 end with a CAGR of over 5.7% during the forecast period 2020 to 2027.

The reagents and antibodies are important components for research in the life science sector for investigating biological processes or identifying the cause of diseases with the help of meticulous experimentation, lab work, observation, testing and analysis. The growing demand for research in genomics and proteomics, increasing insistence for antibodies of high quality for research purposes, rise in the number of research and development activities in life sciences sector are some of the key factors contributing to the research antibodies and reagents market growth. Furthermore, the escalating insistence for personalised medicine and protein therapeutics shall augment the market growth.
The research in neurobiology primarily depends on antibodies in identifying and elucidating cellular, biochemical or molecular reaction levels which helps in analysing the neuroscientific processes. There has been a significant rise in the prevalence of neurological disorders which has paved way for extensive research activities, thereby augmenting the market growth. As per the Research America, the government of the Unites States raised the investment by over 17% between 2014 to 2017. The total expense on health and medical research was over USD 180 billion in 2017. Such factors shall contribute in the proliferation of the market.

Research Antibodies and Reagents Market

Market Segmentation:

By Product
• Reagents
• Antibodies

By Technology
•   Western Blot
•   Immunofluorescence
•   Immunohistochemistry
•   Flow Cytometry
•   Enzyme-Linked Immunosorbent Assay

By Application
•   Proteomics
•   Drug Development
•   Genomics

By End User
•   Pharmaceutical and Biotechnology Companies
•   Academic and Research Institutes
•   Contract Research Organizations

By Region
•   North America
•   Europe
•   Asia-Pacific
•   Latin America
•   Middle East and Africa

The market is categorised into product, technology, application, end user and region. The product segment is fragmented into reagents and antibodies. The reagents segment is predicted to hold the largest research antibodies and reagents market share owing to the increased usage of reagents in multiple research techniques and assays, rising utilization of reagents or understanding the molecular basis of a disease. The technology segment is divided into western blot, immunofluorescence, immunohistochemistry, flow cytometry, enzyme-linked immunosorbent assay (ELISA). The western blot segment is anticipated to lead the market during the forecast period and this is primarily due to increased research fund for discovering biomarkers, cell-based and antibody research and high insistence for efficient testing kits for detecting agents that cause the viral disease.
The application segment is categorised into proteomics, drug development and genomics. The proteomics segment is predicted to dominate the market and this ca n be credited to the rise in the research for anti-cancer drug candidates, the increased necessity for developing effective drugs and assessment of the patient response and drug efficacy. The end user segment is fragmented into pharmaceutical and biotechnology companies, academic and research institutes and contract research organizations. The pharmaceutical and biotechnology companies are predicted to lead the market owing to rise in the investments for research activities, rising acceptance of research reagents and antibodies for proteomics research programs and rising insistence for efficient personalised medicine.

Regional Analysis:

The North America region is anticipated to dominate the market owing to the presence of key market players in the region. The Europe region follows the growth rate of North America during the forecast period. As per the European Union, the Horizon 2020 program launched by the government in 2016 invested over USD 85 billion, of which over 9% was used by the healthcare sector. This program was initiated for supporting and developing personalised medicines.

Competitive Landscape:

Some of the important market players are Abcam plc, Merck KGaA, Cell Signaling Technology Inc., GE Healthcare, Thermo Fisher Scientific Inc., F. Hoffmann La-Roche Ltd., Rockland Immunochemicals Inc., Johnson & Johnson, Agilent Technologies Inc., Eli Lily and Company, Becton Dickinson and Company, Danaher Corporation, PerkinElmer, Inc., GenScript Biotech Corporation, Lonza, Bio-Techne Corporation , Bio-Rad Laboratories, Inc., Teva Pharmaceutical Industries Limited, Santa Cruz Biotechnology Inc., BioLegend, Inc.

FutureWise Key Takeaways:

• Growth prospects
• SWOT analysis
• Key market trends
• Key data-points affecting market growth

Objectives of the Study:

• To provide with an exhaustive analysis on the global research antibodies and reagents market by product, by technology, by application, by end user and by region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa
• To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions

Flexible Delivery Model:

•   We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
•   The customization Mobility Care offered are free of charge with purchase of any license of the report
•   You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com